Bank of America’s VIVEVE MED INC VIVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20
Closed 9030
2021
Q4
$0 Buy
+20
New +$37 ﹤0.01% 8889
2021
Q2
Sell
-163
Closed 8279
2021
Q1
$0 Buy
+163
New +$599 ﹤0.01% 7932
2019
Q3
Sell
-4
Closed -$1K 7615
2019
Q2
$1K Buy
4
+3
+300% +$1.63K ﹤0.01% 7098
2019
Q1
$1K Hold
1
﹤0.01% 7028
2018
Q4
$1K Sell
1
-2
-67% -$4.8K ﹤0.01% 7019
2018
Q3
$8K Sell
3
-8
-73% -$22.7K ﹤0.01% 6733
2018
Q2
$29K Buy
11
+8
+267% +$23K ﹤0.01% 6380
2018
Q1
$9K Sell
3
-13
-81% -$56.5K ﹤0.01% 6644
2017
Q4
$79K Buy
16
+14
+700% +$72.9K ﹤0.01% 5856
2017
Q3
$9K Buy
2
+1
+100% +$6.17K ﹤0.01% 6593
2017
Q2
$7K Hold
1
﹤0.01% 6532
2017
Q1
$6K Hold
1
﹤0.01% 6647
2016
Q4
$5K Buy
+1
New +$5.95K ﹤0.01% 6712

Other funds holding VIVE

Bank of America's VIVE Position: Q1 2022 in Review

Bank of America sold out of VIVEVE MED INC (VIVE) in Q1 2022, closing a stake of 20 shares.

Bank of America first reported a position in VIVE in Q4 2016 and held it in 13 quarters. The position peaked at $79K in Q4 2017. 18 funds tracked by Wall St. Rank hold VIVE as of Q1 2022.

  • Bank of America reported no remaining VIVEVE MED INC position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 20 VIVEVE MED INC shares in Q1 2022.
  • Bank of America first reported a position in VIVEVE MED INC in Q4 2016 and held it in 13 quarters.
  • Bank of America's VIVEVE MED INC position peaked at $79K in Q4 2017.
  • 18 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.